Drug Profile
Nicotinamide
Alternative Names: N 547; Niacinamide; Nicotinamide gel; PapulexLatest Information Update: 06 Jan 2022
Price :
$50
*
At a glance
- Originator GenDerm Corporation; National Institutes of Health (USA); University of Washington
- Developer Euroderma; GenDerm Corporation; University of Washington
- Class Amides; Antiacnes; Antibacterials; Nicotinic acids; Small molecules; Vitamins
- Mechanism of Action Cytokine modulators; JNK mitogen-activated protein kinase inhibitors; Leukocyte modulators; Mitogen-activated protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acne vulgaris
- Discontinued Type 1 diabetes mellitus